Co-recombinogenic and co- or anti-mutagenic effects of non-genotoxic carcinogens in S. cerevisiae MP1

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 16, Issue 4, 1997, Pages 273-279

  Fahrig, Rudolf ^a  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Antigenotoxicity; Antimutagens; Genotoxicity; Mutagens

Indexed keywords

CARCINOGEN;

ANEUPLOIDY; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; DNA REPAIR; GENE MUTATION; GENETIC RECOMBINATION; GENOTOXICITY; MITOGENESIS; MUTAGENESIS; MUTAGENICITY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

EID: 0030727195     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Butterworth EB, Slaga, TJ. Nongenotoxic Mechanisms in Carcinogenesis. 25 Banbury Report, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1987.
2. Ashby J, de Serres FJ, Draper M, Ishidate M, Margolin BH, Matter BE, Shelby MD. Evaluation of short-term tests for carcinogens. Amsterdam: Elsevier Science Publishers, 1985: 1-752.
3. Fahrig R, Steinkamp-Zucht A. Co-recombinogenic and anti-mutagenic effects of diethylhexylphthalate (DEHP), inactiveness of pentachlorophenol (PCP) in the spot test with mice. Mutat Res 1996; 354:59-67.
4. De la Rosa ME, Magnusson J, Ramel C, Nilsson R. Modulation influence of inorganic arsenic on the recombinogenic and mutagenic action of ionizing radiation and alkylating agents in Drosophila melanogaster. Mutation Res 1994; 318:65-71.
5. Fahrig R. Evidence that induction and suppression of mutations and recombinations by chemical mutagens in S. cerevisiae during mitosis are jointly correlated. Molec Gen Genet 1979; 169: 125-139.
6. Fahrig R. Genetic mode of action of cocarcinogens and tumor promoters in yeast and mice. Molec Gen Genet 1984; 194:7-14.
7. Fahrig R. Effects of bile acids an the mutagenicity and recombinogenicity of triethylene melamine in yeast strain MP1 and D61.M. Arch Toxicology 1987; 60:192-197.
8. Fahrig R. Enhancement of carcinogen-induced mutations or recombinations by 12-O-tetradecanoyl-phorbol-13-acetate in the mammalian spot test. J Cancer Res Clin Oncol 1987; 113:61-66.
9. Fahrig R. Co-recombinagenic effects. Mutat Res 1992; 284:185-193.
10. Fahrig R. Genetic effects of dioxins in the spot test with mice. Env Health Perspect 1993; 101: 257-261.
11. Fahrig R. Anti-mutagenic agents are also co-recombinogenic and can be converted into co-mutagens. Mutat Res 1996; 350:59-67.
12. Fahrig R. Anti-recombinogenic and convertible co-mutagenic effects of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and other 5-substituted pyrimidine nucleoside analogs in S. cerevisiae MP1. Mutat Res 1996; 372:133-139.
13. IARC Monographs, 1982; 29:345-389.
14. Kerns WD, Pavkov KL, Donofrio DJ, Gralla EJ, Swenberg JA. Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res 1983; 43:4382-4392.
15. IARC Monographs, 1987; Suppl. 6:321-324.
16. IARC Monographs, 1974; 7:197-202.
17. Flaks B, Trevan MT, Flaks A. An electron microscope study of hepatocellular changes in the rat during chronic treatment with acetamide. Parenchyma, foci and neoplasms. Carcinogenesis 1983; 4:1117-1125.
18. Fleischman RW, Baker JR, Hagopian M, Wade GG, Hayden DW, Smith ER, Weisburger JH, Weisburger EK. Carcinogenesis bioassay of acetamide, hexanamide, adipamide, urea and ptolylurea in mice and rats. J Environ Pathol Toxicol Oncol 1980; 3:149-170.
19. IARC Monographs, 1986; 39:247-276.
20. Fahrig R, Neuhäuser-Klaus A. Positive response of caprolactam in the mammalian spot test. Mutat Res 1989; 224:377-378.
21. Van Duuren BL. Tumor promoting and co-carcinogenic agents in chemical Carcinogenesis. ACS Monogr 1976; 173:24-51.